Oric Pharmaceuticals, Inc. ORIC Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -42.6%-1.3pp | -41.3%-1.5pp | -39.7%+4.1pp | -43.8%+4.6pp | -48.5%+6.3pp | |
| Return on invested capital | -55.9%-2.9pp | -53%-3.2pp | -49.9%+9.2pp | -59.1%+6.3pp | -65.4%+5.4pp | |
| Liquidity | ||||||
| Current ratio | 16.3×+2.2× | 14.1×-0.5× | 14.6×-1.5× | 16.1×+4.1× | 12×+1.4× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $3.94-10.0% | $4.38+6.5% | $4.11-0.8% | $4.15+34.1% | $3.09-11.3% | |
| Valuation | ||||||
| Market capitalization | $976.17M+23.0% | $796.64M-31.6% | $1.17B+30.4% | $893.94M+126% | $396.33M-30.4% | |
| Price / book | 2.3×-1.3× | 2.1×-0.8× | 2.9×+0.1× | 2.8×+1.0× | 1.8×-0.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Oric Pharmaceuticals, Inc.'s ratios come from?
- Every ratio is computed from Oric Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.